Molecular and functional characterization of non voltage-operated Ca entry in gastrointestinal neuroendocrine tumor

Sasi Arunachalam1, Tetyana Zhelay, David R Giovannucci

  • 1Department of Neurosciences, University of Toledo College of Medicine Toledo OH 43614, USA.

Insights

Calcium (Ca2+) entry via non-voltage operated channels is crucial for carcinoid cancer progression. This study identifies store-operated calcium entry (SOCE) in carcinoid cells, suggesting a role in tumor signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Non-voltage operated calcium channels (Ca2+) are implicated in tumor progression across various cancers.
  • Gastroenteropancreatic neuroendocrine tumors (carcinoids) are a significant group of cancers where Ca2+ signaling roles are underexplored.

Purpose of the Study:

  • To investigate the role and mechanisms of Ca2+ entry in human carcinoid cell lines.
  • To characterize the presence and function of store-operated calcium entry (SOCE) and other non-voltage operated Ca2+ channels in carcinoid tumors.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was employed to profile Ca2+ channel expression.
  • Live-cell imaging was used to assess functional store-operated Ca2+ entry (SOCE) after endoplasmic reticulum (ER) Ca2+ store depletion.
  • Pharmacological inhibitors were used to evaluate the impact on Ca2+ influx.

Main Results:

  • Molecular evidence for various non-voltage operated Ca2+ channels was found in carcinoid cell lines.
  • Functional SOCE was confirmed in carcinoid cells, with its activity generally reduced by SOCE inhibitors.
  • Neurotransmitter activation of SOCE was observed in some cell lines, indicating potential roles in signaling.

Conclusions:

  • Carcinoid tumor cells possess functional store-operated calcium entry (SOCE) and other non-voltage operated Ca2+ channels.
  • Ca2+ entry pathways, including SOCE, may play a critical role in mediating neural, paracrine, or autocrine signaling in carcinoid cancers.
  • These findings highlight Ca2+ signaling as a potential therapeutic target in carcinoid oncology.